AZBio Expo 2013
Bridging the Gap
May 30, 2013
9 AM – 4 PMFiesta Resort and Conference Center 2100 South Priest Drive Tempe, Arizona
Sponsors and Supporters
To learn more about the benefits of supporting AZBio, click here
Funding Development in a Changing World
General Session 1
Meet our Panelists:
Les Funtleyder, Healthcare Strategist, Polliwog Investment Advisors
Les Funtleyder is a healthcare strategist at Polliwog, and responsible for the development and management of investment funds and related products. Mr. Funtleyder has been involved with the health care industry since 1993, both as a portfolio manager and analyst, and as an employee of major pharmaceutical companies.
His most recent experience prior to Poliwogg was as portfolio manager and health care strategist for the Miller Tabak Health Care Transformation Fund (Symbol: MTHFX)., which was a ’40 Act mutual fund focused on investing in the most innovative sub-sectors of healthcare. MTHFX achieved top decile performance in the long/short category. He joined Miller Tabak after managing a healthcare equity portfolio for Provident Advisors, a hedge fund located in Minneapolis, Minnesota. Before joining Provident, Mr. Funtleyder worked as a medical device analyst at UBS Warburg. He also covered biotechnology stocks as an analyst at Bigelow and Company.
His direct industry experience includes the direction of clinical and business research at Innovative Health Solutions, a joint venture of Merck and Wyeth; and as a consultant to HMOs and hospitals for Coopers & Lybrand and Health Strategies Group.
Mr. Funtleyder wrote Healthcare Investing: Profiting from the New World of Pharma, Biotech, and Health Care Services (McGraw Hill), published in January 2009, which bridges the gap between health reform, innovation and investing. He is widely quoted in the Wall Street Journal, the New York Times, and the Financial Times, and is a frequent guest on CNBC, Bloomberg and NPR for his unique perspective on the healthcare sector and its constituent companies. He is also on the advisory boards of Healthengine, The Prix Galien Foundation and Pharmaceutical Executive Magazine.
Mr. Funtleyder holds a Master of Public Heath (MPH) from Columbia University and a BA from Tulane University.
Cynthia Tsai currently serves as Chairman and CEO of Viropro, a U.S. publicly traded company working in biosimilars and emerging markets, specifically Malaysia.
Tsai has achieved international recognition for her expertise in private equity financing and development of high-growth companies by securing private capitalization from high-net worth investors.
She spent 16 years on Wall Street as a vice president with Merrill Lynch and Kidder Peabody, working with early stage biotech companies and technology transfer from MIT and other universities. At MIT, Ms Tsai was general partner in MassTech Ventures, a multi-million dollar equity fund focused on technology development. She also previously owned one of the largest consumer health care marketing companies, which was sold in 2002.
Ms. Tsai spent six years (2006-2012) in Washington, DC, working with ExecutiveAction, a global problem solving company and was President of ExecutiveAction Sports and Entertainment, focused on celebrities with issues ranging from blackmailing to kidnapping.
Cynthia serves on the Board of Selectors for the Jefferson Awards for Public Service and is a member of the Board of the Prix Galien Foundation with Mr. Bruno Cohen, Founder of the U.S. Prix Galien. Cynthia lives in Washington, DC and Montana.
Moderator: Kimberly Ha, Global Editor, Biopharm Insight (Financial Times Group)
Kimberly is an award-winning biopharmaceutical industry journalist and editor. She launched BioPharm Insight’s editorial team in 2007. She began her career as a financial journalist in Hong Kong specializing in healthcare M&A, and previously was the lead sector specialist at Mergermarket, a division of the Financial Times Group.
She is a sought-after panelist and moderator at major healthcare investor conferences and events, including the Prix Galien Awards. In 2011, based on her extensive coverage of Alzheimer’s disease, she was nominated by the Alzheimer’s Association and was ultimately selected to be a National Press Foundation Fellow. Kimberly also is a recipient of the 2012 National Press Foundation and UN Foundation Global Vaccines Press Fellowship. In 2012, she was awarded the Association of Health Care Journalists Fellowship Award, which was supported by the New York State Health Foundation as well as the National Press Foundation Cancer Issues Fellowship. She is also on the advisory boards of The Prix Galien Foundation and OneMedPlace.
Kimberly completed her Bachelor’s in Psychology from New York University. She is fluent in Cantonese, Shanghainese, and is proficient in Mandarin.